Epsilon M&A Deal Report - IDmyk (now Eurofins ID Myk)

Transaction Multiples for the Valuation of Private Companies

Eurofins Scientific > IDmyk (now Eurofins ID Myk)

Announced Date : 16 January 2014

Type : Acquisition of Majority Stake

Deal Value : Yes

Acquirer : Eurofins Scientific

Target: IDmyk (now Eurofins ID Myk)

Target Country: France

Sector of activity : Health, Pharmaceuticals & Biotechnology

Business Description :

> Founded in 2000, IDmyk offers laboratory services in the detection, identification and molecu ...

No EMAT : 67214

Transaction multiples available

	EV/Sales	EV/Gross Profit	EV/EBITDA	EV/EBIT	Eq/PBT	P/E	Price to Book
Historic
Current

: Multiple available

n.s : Multiple calculated, but not significant

Rating **

Source: Epsilon Research / EMAT

Comparable Transactions

Number of EMAT Reports : (Health, Pharmaceuticals & Biotechnology) = 1245

Example of comparable transactions on EMAT (same sub-sector):

Date	Acquirer	Target	Country	Multiples	See details
30/04/2014	Private Group led by Salvepar	S2A Group (now Asten Group)	France	*
25/06/2013	Unimedic	Cross Pharma	Sweden	**

Source: Epsilon Research / EMAT

View Report

This report is accessible on EMAT, the reference database for private company acquisition multiples

Example of EMAT Report : click here

View Complete Report

About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

Sectors covered by our analysts

Studies & indices published by Epsilon Research Register to receive (free) publications updates

EMAT Report

Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

Subscribe to EMAT database